Literature DB >> 19117361

Myoclonus-dystonia: an update.

Kiyoka Kinugawa1, Marie Vidailhet, Fabienne Clot, Emmanuelle Apartis, David Grabli, Emmanuel Roze.   

Abstract

Our knowledge of the clinical, neurophysiological, and genetic aspects of myoclonus-dystonia (M-D) has improved markedly in the recent years. Basic research has provided new insights into the complex dysfunctions involved in the pathogenesis of M-D. On the basis of a comprehensive literature search, this review summarizes current knowledge on M-D, with a focus on recent findings. We also propose modified diagnostic criteria and recommendations for clinical management. 2008 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117361     DOI: 10.1002/mds.22425

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  36 in total

Review 1.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

2.  A novel mutation of the SGCE-gene in a German family with myoclonus-dystonia syndrome.

Authors:  Christian Johannes Hartmann; Barbara Leube; Lars Wojtecki; Beate Betz; Stefan Jun Groiss; Peter Bauer; Alfons Schnitzler; Martin Südmeyer
Journal:  J Neurol       Date:  2011-01-26       Impact factor: 4.849

Review 3.  Diagnosis and treatment of dystonia.

Authors:  H A Jinnah; Stewart A Factor
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

Review 4.  Diagnosis of dystonic syndromes--a new eight-question approach.

Authors:  Kelly L Bertram; David R Williams
Journal:  Nat Rev Neurol       Date:  2012-03-20       Impact factor: 42.937

5.  Myoclonus-dystonia and Silver-Russell syndrome resulting from maternal uniparental disomy of chromosome 7.

Authors:  M B Sheridan; A Bytyci Telegrafi; V Stinnett; C C Umeh; Z Mari; T M Dawson; J Bodurtha; D A S Batista
Journal:  Clin Genet       Date:  2013-01-20       Impact factor: 4.438

6.  Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Guang Yang; Jindong Li; Atbin Doroodchi; Tong Zhou; Yuqing Li
Journal:  Behav Brain Res       Date:  2011-10-21       Impact factor: 3.332

7.  Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.

Authors:  Fumiaki Yokoi; Mai T Dang; Tong Zhou; Yuqing Li
Journal:  Hum Mol Genet       Date:  2011-11-11       Impact factor: 6.150

Review 8.  Imprinting evolution and human health.

Authors:  Radhika Das; Daniel D Hampton; Randy L Jirtle
Journal:  Mamm Genome       Date:  2009-10-15       Impact factor: 2.957

Review 9.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

10.  Metabolic changes in DYT11 myoclonus-dystonia.

Authors:  Maren Carbon; Deborah Raymond; Laurie Ozelius; Rachel Saunders-Pullman; Steven Frucht; Vijay Dhawan; Susan Bressman; David Eidelberg
Journal:  Neurology       Date:  2013-01-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.